Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI)

Experimental Neurology

Volumn 208, Issue 2, 2007, Pages 228-237

  Mueller, C A ^a,b   Schluesener, H J ^a   Fauser, U ^a   Conrad, S ^a   Schwab, J M ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antiangiogenesis; CNS injury; Vascular remodelling

Indexed keywords

ANGIOGENESIS INHIBITOR; COLLAGEN TYPE 18; ENDOSTATIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; BRAIN DAMAGE; CELL COUNT; CELL DAMAGE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; ENDOTHELIUM LESION; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MONOCYTE; NECROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STAB WOUND; SUBENDOTHELIUM; TRAUMATIC BRAIN INJURY;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; BRAIN; BRAIN INJURIES; COLLAGEN TYPE XVIII; ENDOSTATINS; MACROPHAGES; MALE; MICROGLIA; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; WOUNDS, STAB;

EID: 36048944802     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.07.020     Document Type: Article

References (67)

1. Baethmann A., Maier-Hauff K., Kempski O., Unterberg A., Wahl M., and Schurer L. Mediators of brain edema and secondary brain damage. Crit. Care Med. 16 (1988) 972-978
2. Bartholdi D., Rubin B.P., and Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 9 (1997) 2549-2560
3. Berger A.C., Feldman A.L., Gnant M.F., Kruger E.A., Sim B.K., Hewitt S., Figg W.D., Alexander H.R., and Libutti S.K. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J. Surg. Res. 91 (2000) 26-31
4. Beschorner R., Engel S., Mittelbronn M., Adjodah D., Dietz K., Schluesener H.J., and Meyermann R. Differential regulation of the monocytic calcium-binding peptides macrophage-inhibiting factor related protein-8 (MRP8/S100A8) and allograft inflammatory factor-1 (AIF-1) following human traumatic brain injury. Acta Neuropathol. (Berl) 100 (2000) 627-634
5. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4 (2001) 702-710
6. Bix G., and Iozzo R.V. Matrix revolutions: "tails" of basement-membrane components with angiostatic functions. Trends Cell Biol. 15 (2005) 52-60
7. Bloch W., Huggel K., Sasaki T., Grose R., Bugnon P., Addicks K., Timpl R., and Werner S. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J. 14 (2000) 2373-2376
8. Bramlett H.M., and Dietrich W.D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 24 (2004) 133-150
9. Chen S., Pickard J.D., and Harris N.G. Time course of cellular pathology after controlled cortical impact injury. Exp. Neurol. 182 (2003) 87-102
10. Coffey P.J., Perry V.H., and Rawlins J.N. An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration. Neuroscience 35 (1990) 121-132
11. Deininger M.H., Meyermann R., and Schluesener H.J. Endostatin/Collagen XVIII accumulates in patients with traumatic brain injury. J. Neurotrauma 23 (2006) 1103-1110
12. Dong S., Cole G.J., and Halfter W. Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J. Biol. Chem. 278 (2003) 1700-1707
13. D'Souza S., Alinauskas K., McCrea E., Goodyer C., and Antel J.P. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15 (1995) 7293-7300
14. Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486 (2000) 247-251
15. Fitch M.T., and Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 148 (1997) 587-603
16. Fitch M.T., Doller C., Combs C.K., Landreth G.E., and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19 (1999) 8182-8198
17. Fujita T., Yoshimine T., Maruno M., and Hayakawa T. Cellular dynamics of macrophages and microglial cells in reaction to stab wounds in rat cerebral cortex. Acta Neurochir. (Wien) 140 (1998) 275-279
18. Fukai N., Eklund L., Marneros A.G., Oh S.P., Keene D.R., Tamarkin L., Niemela M., Ilves M., Li E., Pihlajaniemi T., and Olsen B.R. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21 (2002) 1535-1544
19. Gerlach C., Golding M., Larue L., Alison M.R., and Gerdes J. Ki-67 immunoexpression is a robust marker of proliferative cells in the rat. Lab. Invest. 77 (1997) 697-698
20. Giulian D., Chen J., Ingeman J.E., George J.K., and Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J. Neurosci. 9 (1989) 4416-4429
21. Hajitou A., Grignet C., Devy L., Berndt S., Blacher S., Deroanne C.F., Bajou K., Fong T., Chiang Y., Foidart J.M., and Noel A. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J. 16 (2002) 1802-1804
22. Hawkins B.T., and Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005) 173-185
23. Hirji N., Lin T.J., Bissonnette E., Belosevic M., and Befus A.D. Mechanisms of macrophage stimulation through CD8: macrophage CD8alpha and CD8beta induce nitric oxide production and associated killing of the parasite Leishmania major. J. Immunol. 160 (1998) 6004-6011
24. Hsu C.Y., Hu Z.Y., and Doster S.K. Cell mediated injury. In: Narayan R.K., Wilberger J.E., and Povlishock J.T. (Eds). Neurotrauma (1996), McGraw Hill, New York 1433-1444
25. Imperato-Kalmar E.L., McKinney R.A., Schnell L., Rubin B.P., and Schwab M.E. Local changes in vascular architecture following partial spinal cord lesion in the rat. Exp. Neurol. 145 (1997) 322-328
26. + macrophages/microglia. Eur. J. Neurosci. 10 (1998) 680-688
27. Karumanchi S.A., Jha V., Ramchandran R., Karihaloo A., Tsiokas L., Chan B., Dhanabal M., Hanai J.I., Venkataraman G., Shriver Z., Keiser N., Kalluri R., Zeng H., Mukhopadhyay D., Chen R.L., Lander A.D., Hagihara K., Yamaguchi Y., Sasisekharan R., Cantley L., and Sukhatme V.P. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7 (2001) 811-822
28. Kato H., and Walz W. The initiation of the microglial response. Brain Pathol. 10 (2000) 137-143
29. Kim Y.M., Hwang S., Pyun B.J., Kim T.Y., Lee S.T., Gho Y.S., and Kwon Y.G. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277 (2002) 27872-27879
30. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
31. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., and McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 24 (2001) 169-181
32. Lin B., Ginsberg M.D., Zhao W., Alonso O.F., Belayev L., and Busto R. Quantitative analysis of microvascular alterations in traumatic brain injury by endothelial barrier antigen immunohistochemistry. J. Neurotrauma 18 (2001) 389-397
33. Loy D.N., Crawford C.H., Darnall J.B., Burke D.A., Onifer S.M., and Whittemore S.R. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J. Comp. Neurol. 445 (2002) 308-324
34. Ma L., del Soldato P., and Wallace J.L. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13243-13247
35. Marneros A.G., and Olsen B.R. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20 (2001) 337-345
36. Maxwell W.L., Follows R., Ashhurst D.E., and Berry M. The response of the cerebral hemisphere of the rat to injury: I. The mature rat. Philos. Trans. R. Soc. Lond., B Biol. Sci. 328 (1990) 479-500
37. Maxwell W.L., Povlishock J.T., and Graham D.L. A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma 14 (1997) 419-440
38. McIntosh T.K., Smith D.H., Meaney D.F., Kotapka M.J., Gennarelli T.A., and Graham D.I. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab. Invest. 74 (1996) 315-342
39. Montero-Menei C.N., Sindji L., Garcion E., Mege M., Couez D., Gamelin E., and Darcy F. Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res. 724 (1996) 55-66
40. Morganti-Kossmann M.C., Rancan M., Stahel P.F., and Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 8 (2002) 101-105
41. Mueller C.A., Schluesener H.J., Conrad S., Meyermann R., and Schwab J.M. Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury. J. Neuroimmunol. 135 (2003) 1-9
42. Muragaki Y., Timmons S., Griffith C.M., Oh S.P., Fadel B., Quertermous T., and Olsen B.R. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8763-8767
43. Nag S., Takahashi J.L., and Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56 (1997) 912-921
44. Nag S., Eskandarian M.R., Davis J., and Eubanks J.H. Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury. J. Neuropathol. Exp. Neurol. 61 (2002) 778-788
45. Nag S., Papneja T., Venugopalan R., and Stewart D.J. Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab. Invest. 85 (2005) 1189-1198
46. Oh S.P., Warman M.L., Seldin M.F., Cheng S.D., Knoll J.H., Timmons S., and Olsen B.R. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19 (1994) 494-499
47. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
48. Popovich P.G., van Rooijen N., Hickey W.F., Preidis G., and McGaughy V. Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp. Neurol. 182 (2003) 275-287
49. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377 (1997) 443-464
50. Povlishock J.T., and Kontos H.A. Continuing axonal and vascular change following experimental brain trauma. Cent. Nerv. Syst. Trauma 2 (1985) 285-298
51. Rehn M., and Pihlajaniemi T. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4234-4238
52. Rehn M., Hintikka E., and Pihlajaniemi T. Primary structure of the alpha 1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the alpha 1(XVIII) chain with its homologue, the alpha 1(XV) collagen chain. J. Biol. Chem. 269 (1994) 13929-13935
53. Rehn M., Hintikka E., and Pihlajaniemi T. Characterization of the mouse gene for the alpha 1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters. Genomics 32 (1996) 436-446
54. Riva-Depaty I., Fardeau C., Mariani J., Bouchaud C., and Delhaye-Bouchaud N. Contribution of peripheral macrophages and microglia to the cellular reaction after mechanical or neurotoxin-induced lesions of the rat brain. Exp. Neurol. 128 (1994) 77-87
55. Rodriguez-Baeza A., Reina-de la Torre F., Poca A., Marti M., and Garnacho A. Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 273 (2003) 583-593
56. Schaller B., and Graf R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J. Cereb. Blood Flow Metab. 24 (2004) 351-371
57. Schluesener H.J., Seid K., Kretzschmar J., and Meyermann R. Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque. J. Neurosci. Res. 44 (1996) 606-611
58. Schluesener H.J., Seid K., Zhao Y., and Meyermann R. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells. Glia 20 (1997) 365-372
59. Schmidt A., Wenzel D., Ferring I., Kazemi S., Sasaki T., Hescheler J., Timpl R., Addicks K., Fleischmann B.K., and Bloch W. Influence of endostatin on embryonic vasculo- and angiogenesis. Dev. Dyn. 230 (2004) 468-480
60. Schwab J.M., Seid K., and Schluesener H.J. Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats. J. Neurotrauma 18 (2001) 881-890
61. Skold M.K., von Gertten C., Sandberg-Nordqvist A.C., Mathiesen T., and Holmin S. VEGF and VEGF receptor expression after experimental brain contusion in rat. J. Neurotrauma 22 (2005) 353-367
62. Skold M.K., Risling M., and Holmin S. Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. Eur. J. Neurosci. 23 (2006) 21-34
63. Streit W.J., and Kreutzberg G.W. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J. Comp. Neurol. 268 (1988) 248-263
64. Strik H.M., Schluesener H.J., Seid K., Meyermann R., and Deininger M.H. Localization of endostatin in rat and human gliomas. Cancer 91 (2001) 1013-1019
65. Sudhakar A., Sugimoto H., Yang C., Lively J., Zeisberg M., and Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4766-4771
66. Takahashi K., Saishin Y., Silva R.L., Oshima Y., Oshima S., Melia M., Paszkiet B., Zerby D., Kadan M.J., Liau G., Kaleko M., Connelly S., Luo T., and Campochiaro P.A. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J. 17 (2003) 896-898
67. Wenzel D., Schmidt A., Reimann K., Hescheler J., Pfitzer G., Bloch W., and Fleischmann B.K. Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ. Res. 98 (2006) 1203-1211